Canara Robeco Pharma Fund - Regular Plan - Growth

Canara Robeco Pharma Fund - Regular Plan - Growth – Poora parichay aur strategy

Canara Robeco Pharma Fund - Regular Plan - Growth ek equity mutual fund hai, jo Pharma sector mein invest karta hai. Iska primary objective hai investors ko long-term capital appreciation provide karna. Ye fund aggressive growth seekers ke liye suitable hai jo healthcare aur pharmaceutical sector ki potential growth ko samajhte hain. Fund ka investment style growth-oriented hai, jahan long-term trends aur market dynamics ko dhyan mein rakha jata hai. Agar aapko high growth mutual funds mein interest hai, toh ye fund aapke liye accha option ho sakta hai. Chaliye, iske top holdings aur portfolio allocation ko samajhte hain.

Canara Robeco Pharma Fund - Regular Plan - Growth ke returns – 1, 3, 5 saal ke aankde

Canara Robeco Pharma Fund - Regular Plan - Growth ka performance benchmark Nifty Pharma TRI ke against compare karne par kuch interesting insights milte hain.

Time Period	Fund Returns (%)	Benchmark Returns (%)
1 Year	-2.18%	data not available
3 Years	4.81%	data not available
5 Years	4.46%	data not available

Agar hum in returns ko dekhein, toh 1 saal ka return negative hai, jo market volatility ko reflect karta hai. Lekin 3 aur 5 saal ke returns consistent hai, jo ki long-term investment ke liye encouraging hai. Fund manager Shridatta Bhandwaldar ka experience bhi is fund ki performance par achha prabhav dalta hai. Unka strategic decision-making aur market ki samajh is fund ki volatility ko manage karne mein madad karti hai. Ye investors ko long-term wealth creation mein help kar sakta hai.

Canara Robeco Pharma Fund - Regular Plan - Growth top holdings and portfolio allocation

Is fund ki top holdings mein kuch renowned companies hain. Ye holdings fund ki overall strategy aur sector exposure ko reflect karti hain.

• Sun Pharmaceutical Industries Ltd. - 20.5%
• Dr. Reddy's Laboratories Ltd. - 12.8%
• Cipla Ltd. - 10.4%
• Divi's Laboratories Ltd. - 9.8%
• Torrent Pharmaceuticals Ltd. - 7.2%

Fund ka overall portfolio Pharma sector ke diversified stocks se bhara hua hai, jo ki overall sector growth ko capture karta hai. Sector allocation bhi interesting hai, kyunki ye fund healthcare ki emerging trends ko bhi consider karta hai. Ye strategy long-term investors ke liye faydemand ho sakti hai, kyunki healthcare sector mein growth potential hai aur market volatility ke dauran bhi stable rehne ki ability hai.

Canara Robeco Pharma Fund - Regular Plan - Growth – risk level aur volatility

Is fund ka riskometer "Very High" hai, jo iska high-risk nature dikhata hai. Agar aap aggressive investor hain jo high returns ki talash mein hain, toh ye fund aapke liye sahi ho sakta hai. Lekin, high volatility bhi hoti hai, jo aapke investment par prabhav dal sakti hai. Sharpe ratio ka data available nahi hai, par ye dhyan mein rakhna zaroori hai ki high-risk investments mein volatility zyada hoti hai. Is fund ke liye suitable investors unhein samajhna chahiye ki unhe market fluctuations ke dauran patience rakhna padega.

Canara Robeco Pharma Fund - Regular Plan - Growth – fayde aur nuksan

• Pros:
• Sector-specific expertise with strong fund manager.
• Potential for high returns in the long term.
• Diversified portfolio with top Pharma companies.
• Suitable for aggressive investors seeking growth.

• Cons:
• High risk and volatility can be challenging.
• Negative performance in the short term.
• Expense ratio of 1.95% might be high for some investors.